Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
IMA
$8.79
+1.03%
Analyze
1M
+14.0%
00
Market Cap:
0
ImageneBio, Inc.
Healthcare |
Biotechnology
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company is headquartered in San Diego, California.
Click "Analyze" to generate stock analysis
IMA Price Trend and Signals
IMA Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis